DBV Technologies (DBVT) Cash from Operations (2020 - 2026)
DBV Technologies (DBVT) reported Cash from Operations of 49100000.0 for Q1 2026, down 149.24% year-over-year from 99718556.7 in Q1 2025, and down 39.6% quarter-over-quarter from 35173000.0 in Q4 2025.
DBV Technologies (DBVT) Cash from Operations (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Cash from Operations data on file, last reported at 49100000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 49100000.0, down 149.24% year-over-year; the trailing twelve-month figure through Mar 2026 was 150581000.0 (down 68.28% YoY), and the FY2025 annual result was 121181000.0, down 15.99% from the prior year.
- Cash from Operations slipped to 49100000.0 in Q1 2026 per DBVT's latest filing, from 35173000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1483000.0 in Q1 2022 and troughed at 49100000.0 in Q1 2026.
- A 5-year average of 24122000.0 and a median of 22457000.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations jumped 95.9% in 2022, then slumped 1305.33% in 2023.
- A 5-year view of Cash from Operations shows it stood at 23885000.0 in 2022, then jumped by 42.7% to 13686000.0 in 2023, then climbed by 10.48% to 12252000.0 in 2024, then sank by 187.08% to 35173000.0 in 2025, then plunged by 39.6% to 49100000.0 in 2026.
- Business Quant data shows DBVT's Cash from Operations at 49100000.0 in Q1 2026, 35173000.0 in Q4 2025, and 32435000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -49.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.10 Mn |
| Mar 31, 2026 | -49.10 Mn |
| Dec 31, 2025 | -35.17 Mn |
| Dec 31, 2025 | -35.17 Mn |
| Sep 30, 2025 | -32.44 Mn |
| Sep 30, 2025 | -32.44 Mn |
| Jun 30, 2025 | -33.87 Mn |
| Jun 30, 2025 | -33.87 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | -12.25 Mn |
| Dec 31, 2024 | -12.25 Mn |
| Sep 30, 2024 | -22.46 Mn |
| Sep 30, 2024 | -22.46 Mn |
| Jun 30, 2024 | -35.07 Mn |
| Jun 30, 2024 | -35.07 Mn |
| Mar 31, 2024 | -34.69 Mn |
| Mar 31, 2024 | -34.69 Mn |
| Dec 31, 2023 | -13.69 Mn |
| Dec 31, 2023 | -13.69 Mn |